BDPT — BioAdaptives Cashflow Statement
0.000.00%
Last trade - 00:00- $0.13m
- $0.51m
- $0.02m
Annual cashflow statement for BioAdaptives, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.05 | -0.896 | -0.712 | -0.899 | -1.56 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.522 | 0.424 | 0.44 | 0.571 | 0.917 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.235 | 0.182 | 0.02 | 0.077 | 0.121 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.159 | -0.227 | -0.224 | -0.25 | -0.516 |
| Capital Expenditures | — | — | — | — | -0.018 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | — | — | -0.018 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.237 | 0.17 | 0.259 | 0.326 | 0.555 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.078 | -0.058 | 0.035 | 0.077 | 0.021 |